« Health Reform Whitepaper: Employer Impact of PPACA | Main | Health Reform Whitepaper: Strengthening the Fraud and Abuse Laws »

07/19/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e551db42b488330133f265755a970b

Listed below are links to weblogs that reference Health Reform Update - Provider Impact:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

A subgroup in the trial noted that docosanol stopped cold sore episodes from progressing to the blister stage in 34% of patients who applied it at the early sign of an outbreak (redness) compared to 23% in the equivalent placebo group.

The comments to this entry are closed.